167 related articles for article (PubMed ID: 10999085)
1. Comparison of two schedules of hepatitis B vaccination in patients with mild, moderate and severe renal failure.
Agarwal SK; Irshad M; Dash SC
J Assoc Physicians India; 1999 Feb; 47(2):183-5. PubMed ID: 10999085
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B vaccination in predialysis chronic renal failure patients a comparison of two vaccination schedules.
McNulty CA; Bowen JK; Williams AJ
Vaccine; 2005 Jul; 23(32):4142-7. PubMed ID: 15913854
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the response to the recombinant vaccine against hepatitis B virus in dialyzed and nondialyzed children with CRF using different doses and routes of administration.
Vazquez G; Mendoza-Guevara L; Alvarez T; Aguilar A; Morales A; Rodriguez F; Solorzano F; Garcia-Lopez E; Muñoz O
Adv Perit Dial; 1997; 13():291-6. PubMed ID: 9360702
[TBL] [Abstract][Full Text] [Related]
4. The evaluation of the effectiveness of multiple dose intradermal hepatitis B re-vaccination in hemodialyzed patients not responding to standard method of immunization.
Radziszewski A; Gajda M; Pituch-Noworolska A; Drozdz M; Kraśniak A; Kaczmarczyk I; Hołyś S; Zurowski J; Sydor A; Sułowicz W
Przegl Lek; 2007; 64(7-8):470-5. PubMed ID: 18409347
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
[TBL] [Abstract][Full Text] [Related]
6. Low response to HBsAg vaccine in chronic renal failure patients is not due to intrinsic defect of B cells.
Krishnamurthy G; Kher V; Naik S
Scand J Urol Nephrol; 2002; 36(5):377-82. PubMed ID: 12487744
[TBL] [Abstract][Full Text] [Related]
7. A comparison of responsiveness to hepatitis B vaccination in patients on hemodialysis and peritoneal dialysis.
Liu YL; Kao MT; Huang CC
Vaccine; 2005 Jun; 23(30):3957-60. PubMed ID: 15917117
[TBL] [Abstract][Full Text] [Related]
8. Intradermal hepatitis B vaccination in patients with advanced chronic renal failure: immunogenicity and follow-up.
Morais EO; Resende MR; Oliveira AM; Sinkoc VM; Garcia MT; Angerami RN; da Silva LJ
Aliment Pharmacol Ther; 2007 Apr; 25(7):849-55. PubMed ID: 17373924
[TBL] [Abstract][Full Text] [Related]
9. Anti-HBs profiles in children treated for neoplastic disease who had been vaccinated against hepatitis B postnatally or as infants.
Koltan S; Koltan A; Wysocki M; Debski R; Styczynski J
J Hosp Infect; 2005 May; 60(1):73-7. PubMed ID: 15823661
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy of vaccination against hepatitis B in adult with HIV infection].
Kalinowska-Nowak A; Bociaga-Jasik M; Garlicki A; Mach T
Przegl Epidemiol; 2007; 61(2):339-47. PubMed ID: 17956052
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of intradermal hepatitis B vaccination compared to intramuscular vaccination in hemodialysis patients.
Chanchairujira T; Chantaphakul N; Thanwandee T; Ong-Ajyooth L
J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S33-40. PubMed ID: 17044452
[TBL] [Abstract][Full Text] [Related]
12. The effect of high dose and short interval HBV vaccination in individuals with chronic hepatitis C.
Idilman R; De MN; Colantoni A; Nadir A; Van Thiel DH
Am J Gastroenterol; 2002 Feb; 97(2):435-9. PubMed ID: 11866284
[TBL] [Abstract][Full Text] [Related]
13. Clinical experience with a new recombinant hepatitis-B vaccine in previous non-responders with chronic renal insufficiency.
Haubitz M; Ehlerding G; Beigel A; Heuer U; Hemmerling AE; Thoma HA
Clin Nephrol; 1996 Mar; 45(3):180-2. PubMed ID: 8706359
[TBL] [Abstract][Full Text] [Related]
14. Comparative immunogenicity of 2 recombinant hepatitis B vaccines (GeneVac-B and Engerix-B) in adult patients with chronic renal failure.
Rajapurkar MM; Gang S; Dabhi M; Kulkarni PS
J Nephrol; 2007; 20(5):596-601. PubMed ID: 17918146
[TBL] [Abstract][Full Text] [Related]
15. A two-dose schedule for combined hepatitis A and B vaccination in children aged 6-15 years.
Kurugöl Z; Mutlubaş F; Ozacar T
Vaccine; 2005 Apr; 23(22):2876-80. PubMed ID: 15780736
[TBL] [Abstract][Full Text] [Related]
16. Response to hepatitis B vaccination in high risk population.
Prakash C; Bhatia R; Kumari S; Verghese T; Datta KK
J Commun Dis; 2000 Mar; 32(1):17-21. PubMed ID: 11129560
[TBL] [Abstract][Full Text] [Related]
17. Response to hepatitis B virus vaccination in haemodialysis patients with and without hepatitis C infection.
Sorkhi H; Roushan MR; Al Hashemi GH; Dooki MR; Bai S
East Mediterr Health J; 2008; 14(4):798-803. PubMed ID: 19166162
[TBL] [Abstract][Full Text] [Related]
18. The response of isolated anti-HBc positive subjects to recombinant hepatitis B vaccine.
Ural O; Findik D
J Infect; 2001 Oct; 43(3):187-90. PubMed ID: 11798257
[TBL] [Abstract][Full Text] [Related]
19. Long-term efficacy of plasma-derived and recombinant hepatitis B vaccines in a rural township of Central Taiwan.
Kao JT; Wang JH; Hung CH; Yen YH; Hung SF; Hu TH; Lee CM; Lu SN
Vaccine; 2009 Mar; 27(12):1858-62. PubMed ID: 19186203
[TBL] [Abstract][Full Text] [Related]
20. Double-dose accelerated hepatitis B vaccine in patients with end-stage liver disease.
Arslan M; Wiesner RH; Sievers C; Egan K; Zein NN
Liver Transpl; 2001 Apr; 7(4):314-20. PubMed ID: 11303291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
